Interview, Podcast, Other
The Future of ‘Femtech’
Goldman SachsAnn Roberts, Lea von Bidder, Dr. Peter Kecskemethy, Antonia Riera, Allison Nathan, Leah Von Bitter
- Flow Health projects revenue growth exceeding 107% over the past four months and anticipates active subscriber expansion at a 4x year-on-year rate, with plans to integrate partners and men into its user journey to shift engagement from a female-centric model.
- Flow Health may pursue FDA regulation in the future should it develop features capable of identifying condition risks, providing diagnostic advice, or entering the fertility and contraception sectors.
- Chiron Medical intends to expand its AI capabilities from breast cancer screening to other cancer areas and anatomical sites, leveraging a long-term vision to treat cancer across all genders to reduce fear associated with the disease.
- Chiron Medical identifies a shifting demand for growth capital to fund large-scale clinical trials and AI implementation, with expectations that the "next wave" will involve increased complexity in securing such funding.
- Ava plans to continuously develop new applications using large datasets and AI algorithms with a specific near-term focus on contraceptive, pregnancy, and menopause applications, while intending to maintain a strategic focus on women's health without expanding to other demographics.
- The Femtech sector is expected to mature to produce large-scale successes such as Series D investments, IPOs, and major exits similar to Fintech, though current outcomes have not yet reached that scale.
- Long-term healthcare digitization is projected to be driven by rising health costs linked to an aging population, government spending constraints, and the catalytic effect of the COVID-19 pandemic on the adoption of digital tools by practitioners and governments.
- Industry analysis and evaluation of healthcare AI are maturing to enable solid technology integration, with an expectation that safe AI deployment in everyday practice will break down barriers and demonstrate effective innovation to the broader market.
- Technologies currently applied to women's health are anticipated to eventually extend to other populations, treatments, conditions, and illnesses, although such applications are not yet widely visible.
- Antonia Riera anticipates that increased healthcare costs and potential government spending constraints will drive long-term digitization, while the pandemic is expected to serve as a catalyst for sustained adoption of digital tools.
- Peter Ketch-Kometi and Leah Von Bitter express expectations for solid technology integration and an increased volume of products brought to market, respectively, as companies leverage AI to lead industry innovation.